No new patients should take Lilly's cancer drug Lartruvo, say regulators - pharmaphorum https://t.co/erfvhZfUIC — Discovery Institute (@discoverynj) January 28, 2019
No new patients should take Lilly's cancer drug Lartruvo, say regulators - pharmaphorum https://t.co/erfvhZfUIC
No comments:
Post a Comment